The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Resveratrol Selectively Remodels Soluble Oligomers and Fibrils of Amyloid Aβ into Off-pathway Conformers
Open accessAbstract
Misfolded proteins associated with diverse aggregation disorders assemble not only into a single toxic conformer but rather into a suite of aggregated conformers with unique biochemical properties and toxicities. To what extent small molecules can target and neutralize specific aggregated conformers is poorly understood. Therefore, we have investigated the capacity of resveratrol to recognize and remodel five conformers (monomers, soluble oligomers, non-toxic oligomers, fibrillar intermediates, and amyloid fibrils) of the Abeta1-42 peptide associated with Alzheimer disease. We find that resveratrol selectively remodels three of these conformers (soluble oligomers, fibrillar intermediates, and amyloid fibrils) into an alternative aggregated species that is non-toxic, high molecular weight, and unstructured. Surprisingly, resveratrol does not remodel non-toxic oligomers or accelerate Abeta monomer aggregation despite that both conformers possess random coil secondary structures indistinguishable from soluble oligomers and significantly different from their beta-sheet rich, fibrillar counterparts. We expect that resveratrol and other small molecules with similar conformational specificity will aid in illuminating the conformational epitopes responsible for Abeta-mediated toxicity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Protein Misfolding, Functional Amyloid, and Human Disease
Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,423
Prusiner, S. B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13363 · Cited by 5,373
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Therapeutic potential of resveratrol: the in vivo evidence
Baur, J. A., & Sinclair, D. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2060 · Cited by 3,958
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336
Jarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178
3D structure of Alzheimer's amyloid-β(1–42) fibrils
Lührs, T., Ritter, C., Adrian, M., Riek-Loher, D., Bohrmann, B., Döbeli, H., Schubert, D., & Riek, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506723102 · Cited by 1,996
Molecular Biology of Prion Diseases
Prusiner, S. B. (1991) · Science · doi:10.1126/science.1675487 · Cited by 1,988
Petkova, A. T., Ishii, Y., Balbach, J. J., Antzutkin, O. N., Leapman, R. D., Delaglio, F., & Tycko, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262663499 · Cited by 1,845
Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes
Milne, J. C., Lambert, P. D., Schenk, S., Carney, D. P., Smith, J. J., Gagne, D. J., Jin, L., Boss, O., Perni, R. B., Vu, C. B., et al. (2007) · Nature · doi:10.1038/nature06261 · Cited by 1,707
Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils
Petkova, A. T., Leapman, R. D., Guo, Z., Yau, W.-M., Mattson, M. P., & Tycko, R. (2005) · Science · doi:10.1126/science.1105850 · Cited by 1,687
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
Ehrnhoefer, D. E., Bieschke, J., Boeddrich, A., Herbst, M., Masino, L., Lurz, R., Engemann, S., Pastore, A., & Wanker, E. E. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1437 · Cited by 1,434
Folding proteins in fatal ways
Selkoe, D. J. (2003) · Nature · doi:10.1038/nature02264 · Cited by 1,417
Eight prion strains have PrPSc molecules with different conformations
Safar, J., Wille, H., Itri, V., Groth, D., Serban, H., Torchia, M., Cohen, F. E., & Prusiner, S. B. (1998) · Nature Medicine · doi:10.1038/2654 · Cited by 1,245
Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrils
Paravastu, A. K., Leapman, R. D., Yau, W.-M., & Tycko, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806270105 · Cited by 1,160
A possible role for π‐stacking in the self‐assembly of amyloid fibrils
Gazit, E. (2002) · The FASEB Journal · doi:10.1096/fj.01-0442hyp · Cited by 1,133
Amyloid fibrillogenesis: themes and variations
Rochet, J.-C., & Lansbury, P. T. (2000) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(99)00049-4 · Cited by 1,095
EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
Bieschke, J., Russ, J., Friedrich, R. P., Ehrnhoefer, D. E., Wobst, H., Neugebauer, K., & Wanker, E. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0910723107 · Cited by 1,011
The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways
Kelly, J. W. (1998) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(98)80016-x · Cited by 1,001
Serio, T. R., Cashikar, A. G., Kowal, A. S., Sawicki, G. J., Moslehi, J. J., Serpell, L., Arnsdorf, M. F., & Lindquist, S. L. (2000) · Science · doi:10.1126/science.289.5483.1317 · Cited by 963
Alzheimer's Disease--Genotypes, Phenotype, and Treatments
Selkoe, D. J. (1997) · Science · doi:10.1126/science.275.5300.630 · Cited by 875
Opposing activities protect against age-onset proteotoxicity
Cohen, E., Bieschke, J., Perciavalle, R. M., Kelly, J. W., & Dillin, A. (2006) · Science · doi:10.1126/science.1124646 · Cited by 843
Katzman, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198604103141506 · Cited by 801
Structural Classification of Toxic Amyloid Oligomers
Glabe, C. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800016200 · Cited by 783
Kayed, R., Head, E., Sarsoza, F., Saing, T., Cotman, C. W., Necula, M., Margol, L., Wu, J., Breydo, L., Thompson, J. L., et al. (2007) · Molecular Neurodegeneration · doi:10.1186/1750-1326-2-18 · Cited by 773
Conformational variations in an infectious protein determine prion strain differences
Tanaka, M., Chien, P., Naber, N., Cooke, R., & Weissman, J. S. (2004) · Nature · doi:10.1038/nature02392 · Cited by 770
Structure–neurotoxicity relationships of amyloid β-protein oligomers
Ono, K., Condron, M. M., & Teplow, D. B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905127106 · Cited by 770
Ono, K., Yoshiike, Y., Takashima, A., Hasegawa, K., Naiki, H., & Yamada, M. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01976.x · Cited by 681
Necula, M., Kayed, R., Milton, S., & Glabe, C. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608207200 · Cited by 680
Bessen, R. A., & Marsh, R. F. (1994) · Journal of Virology · doi:10.1128/jvi.68.12.7859-7868.1994 · Cited by 665
Heise, H., Hoyer, W., Becker, S., Andronesi, O. C., Riedel, D., & Baldus, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506109102 · Cited by 647
A causative link between the structure of aberrant protein oligomers and their toxicity
Campioni, S., Mannini, B., Zampagni, M., Pensalfini, A., Parrini, C., Evangelisti, E., Relini, A., Stefani, M., Dobson, C. M., Cecchi, C., et al. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.283 · Cited by 552
Aguzzi, A., & Polymenidou, M. (2004) · Cell · doi:10.1016/s0092-8674(03)01031-6 · Cited by 544
Inhibition of Heparin-induced Tau Filament Formation by Phenothiazines, Polyphenols, and Porphyrins
Taniguchi, S., Suzuki, N., Masuda, M., Hisanaga, S.-I., Iwatsubo, T., Goedert, M., & Hasegawa, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408714200 · Cited by 540
Non-genetic propagation of strain-specific properties of scrapie prion protein
Bessen, R. A., Kocisko, D. A., Raymond, G. J., Nandan, S., Lansbury, P. T., & Caughey, B. (1995) · Nature · doi:10.1038/375698a0 · Cited by 525
Huntingtin aggregation and toxicity in Huntington's disease
Bates, G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13304-1 · Cited by 525
Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation
Chen, S., Ferrone, F. A., & Wetzel, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182276099 · Cited by 523
Mechanism of Prion Propagation: Amyloid Growth Occurs by Monomer Addition
Collins, S. R., Douglass, A., Vale, R. D., & Weissman, J. S. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020321 · Cited by 515
Reduced IGF-1 signaling delays age-associated proteotoxicity in mice
Cohen, E., Paulsson, J. F., Blinder, P., Burstyn-Cohen, T., Du, D., Estepa, G., Adame, A., Pham, H. M., Holzenberger, M., Kelly, J. W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.11.014 · Cited by 488
Bruce, M., Chree, A., McConnell, I., Foster, J., Pearson, G., & Fraser, H. (1994) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1994.0036 · Cited by 479
Bessen, R. A., & Marsh, R. F. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.2096-2101.1992 · Cited by 446
Bruce, M. E., McConnell, I., Fraser, H., & Dickinson, A. G. (1991) · Journal of General Virology · doi:10.1099/0022-1317-72-3-595 · Cited by 388
Amyloid β-Protein Oligomerization
Bitan, G., Lomakin, A., & Teplow, D. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102223200 · Cited by 387
Polymorphism in the intermediates and products of amyloid assembly
Kodali, R., & Wetzel, R. (2007) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2007.01.007 · Cited by 376
Török, M., Milton, S., Kayed, R., Wu, P., McIntire, T., Glabe, C. G., & Langen, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205659200 · Cited by 373
Wang, J., Ho, L., Zhao, W., Ono, K., Rosensweig, C., Chen, L., Humala, N., Teplow, D. B., & Pasinetti, G. M. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0364-08.2008 · Cited by 361
Conformational Abs recognizing a generic amyloid fibril epitope
O'Nuallain, B., & Wetzel, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022662599 · Cited by 333
Reinke, A. A., & Gestwicki, J. E. (2007) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2007.00557.x · Cited by 329
Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation
Feng, Y., Wang, X.-P., Yang, S.-G., Wang, Y.-J., Zhang, X., Du, X.-T., Sun, X.-X., Zhao, M., Huang, L., & Liu, R.-T. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.08.013 · Cited by 295
Crick, S. L., Jayaraman, M., Frieden, C., Wetzel, R., & Pappu, R. V. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608175103 · Cited by 289
Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters
Bessen, R. A., & Marsh, R. F. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-2-329 · Cited by 287
Development of tau aggregation inhibitors for alzheimer's disease
Bulic, B., Pickhardt, M., Schmidt, B., Mandelkow, E., Waldmann, H., & Mandelkow, E. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200802621 · Cited by 286
Kinetics and Thermodynamics of Amyloid Fibril Assembly
Wetzel, R. (2006) · Accounts of Chemical Research · doi:10.1021/ar050069h · Cited by 284
Multiple Assembly Pathways Underlie Amyloid-β Fibril Polymorphisms
Goldsbury, C., Frey, P., Olivieri, V., Aebi, U., & Müller, S. A. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.07.029 · Cited by 273
Investigation of α-Synuclein Fibril Structure by Site-directed Spin Labeling
Chen, M., Margittai, M., Chen, J., & Langen, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700368200 · Cited by 233
Porat, Y., Mazor, Y., Efrat, S., & Gazit, E. (2004) · Biochemistry · doi:10.1021/bi048582a · Cited by 226
Conformational Diversity of Wild-type Tau Fibrils Specified by Templated Conformation Change
Frost, B., Ollesch, J., Wille, H., & Diamond, M. I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805627200 · Cited by 224
Inhibitory activity of stilbenes on Alzheimer’s β-amyloid fibrils in vitro
Rivière, C., Richard, T., Quentin, L., Krisa, S., Mérillon, J.-M., & Monti, J.-P. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.09.069 · Cited by 214
Methylene Blue Inhibits Amyloid Aβ Oligomerization by Promoting Fibrillization
Necula, M., Breydo, L., Milton, S., Kayed, R., van der Veer, W. E., Tone, P., & Glabe, C. G. (2007) · Biochemistry · doi:10.1021/bi700411k · Cited by 213
Recognition Sequence Design for Peptidyl Modulators of β-Amyloid Aggregation and Toxicity
Pallitto, M. M., Ghanta, J., Heinzelman, P., Kiessling, L. L., & Murphy, R. M. (1999) · Biochemistry · doi:10.1021/bi982119e · Cited by 210
Polymorphic Fibril Formation by Residues 10–40 of the Alzheimer’s β-Amyloid Peptide
Paravastu, A. K., Petkova, A. T., & Tycko, R. (2006) · Biophysical Journal · doi:10.1529/biophysj.105.076927 · Cited by 207
Margittai, M., & Langen, R. (2008) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583508004733 · Cited by 175
Conformation‐Dependent Anti‐Amyloid Oligomer Antibodies
Kayed, R., & Glabe, C. G. (2006) · Methods in Enzymology · doi:10.1016/s0076-6879(06)13017-7 · Cited by 166
Bhattacharyya, A. M., Thakur, A. K., & Wetzel, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501651102 · Cited by 165
Wu, J. W., Breydo, L., Isas, J. M., Lee, J., Kuznetsov, Y. G., Langen, R., & Glabe, C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.069542 · Cited by 158
Blanchard, B. J., Chen, A., Rozeboom, L. M., Stafford, K. A., Weigele, P., & Ingram, V. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405941101 · Cited by 149
Amyloid Protofibrils of Lysozyme Nucleate and Grow Via Oligomer Fusion
Hill, S. E., Robinson, J., Matthews, G., & Muschol, M. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2009.01.044 · Cited by 145
Conformational diversity in a yeast prion dictates its seeding specificity
Chien, P., & Weissman, J. S. (2001) · Nature · doi:10.1038/35065632 · Cited by 145
Prion recognition elements govern nucleation, strain specificity and species barriers
Tessier, P. M., & Lindquist, S. L. (2007) · Nature · doi:10.1038/nature05848 · Cited by 141
Self-citationHudson, S. A., Ecroyd, H. W., Dehle, F. C., Musgrave, I., & Carver, J. A. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.07.031 · Cited by 141
Plakoutsi, G., Bemporad, F., Calamai, M., Taddei, N., Dobson, C. M., & Chiti, F. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.06.043 · Cited by 139
Characterization of the nucleation barriers for protein aggregation and amyloid formation
Auer, S., Dobson, C. M., & Vendruscolo, M. (2007) · HFSP journal · doi:10.2976/1.2760023 · Cited by 137
A comparison of some biological characteristics of the mouse-passaged scrapie agents, 22A and ME7
Dickinson, A. G., & Meikle, V. M. H. (1969) · Genetics Research · doi:10.1017/s0016672300002895 · Cited by 136
Skálová, T., Dohnálek, J., Spiwok, V., Lipovová, P., Vondráčková, E., Petroková, H., Dušková, J., Strnad, H., Králová, B., & Hašek, J. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.08.028 · Cited by 118
Molecules that Target beta‐Amyloid
Stains, C. I., Mondal, K., & Ghosh, I. (2007) · ChemMedChem · doi:10.1002/cmdc.200700140 · Cited by 113
Seeding-dependent Propagation and Maturation of Amyloid Fibril Conformation
Yamaguchi, K.-I., Takahashi, S., Kawai, T., Naiki, H., & Goto, Y. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.07.061 · Cited by 100
Propagation of prion strains through specific conformers of the prion protein
Scott, M. R. D., Groth, D., Tatzelt, J., et al. (1997) · Journal of Virology · doi:10.1128/jvi.71.12.9032-9044.1997 · Cited by 90
Phthalocyanine Tetrasulfonates Affect the Amyloid Formation and Cytotoxicity of α-Synuclein
Lee, E.-N., Cho, H.-J., Lee, C.-H., Lee, D., Chung, K. C., & Paik, S. R. (2004) · Biochemistry · doi:10.1021/bi0356707 · Cited by 86
Filaments of the Ure2p prion protein have a cross-β core structure
Baxa, U., Cheng, N., Winkler, D. C., Chiu, T. K., Davies, D. R., Sharma, D., Inouye, H., Kirschner, D. A., Wickner, R. B., & Steven, A. C. (2005) · Journal of Structural Biology · doi:10.1016/j.jsb.2005.02.007 · Cited by 75
Moretto, N., Bolchi, A., Rivetti, C., Imbimbo, B. P., Villetti, G., Pietrini, V., Polonelli, L., Signore, S. J. D., Smith, K. M., Ferrante, R. J., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609690200 · Cited by 70
Modification of a Strain of Mouse-adapted Scrapie by Passage through Rats
Pattison, I. H., & Jones, K. M. (1968) · Research in Veterinary Science · doi:10.1016/s0034-5288(18)34525-9 · Cited by 70
The Quest for Small Molecules as Amyloid Inhibiting Therapies for Alzheimer's Disease
Amijee, H., & Scopes, D. I. C. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1044 · Cited by 68
Radovan, D., Opitz, N., & Winter, R. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.03.059 · Cited by 66
Model Discrimination and Mechanistic Interpretation of Kinetic Data in Protein Aggregation Studies
Bernacki, J. P., & Murphy, R. M. (2009) · Biophysical Journal · doi:10.1016/j.bpj.2008.12.3903 · Cited by 66
Mukhopadhyay, S., Nayak, P. K., Udgaonkar, J. B., & Krishnamoorthy, G. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.02.006 · Cited by 66
Kumar, S., Mohanty, S. K., & Udgaonkar, J. B. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.01.039 · Cited by 63
Amyloid Nucleation and Hierarchical Assembly of Ure2p Fibrils
Jiang, Y., Li, H., Zhu, L. Q., Zhou, J.-M., & Perrett, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310494200 · Cited by 55
Wang, H., Duennwald, M. L., Roberts, B. E., Rozeboom, L. M., Zhang, Y. L., Steele, A. D., Krishnan, R., Su, L. J., Griffin, D., Mukhopadhyay, S., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801934105 · Cited by 53
Spin Labeling Analysis of Amyloids and Other Protein Aggregates
Margittai, M., & Langen, R. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)13007-4 · Cited by 52
Molecular aspects of Huntington's disease
Walling, H. W., Baldassare, J. J., & Westfall, T. C. (1998) · Journal of Neuroscience Research · Cited by 52
Therapeutic Approaches to Polyglutamine Diseases: Combating Protein Misfolding and Aggregation
Herbst, M., & Wanker, E. E. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206777698828 · Cited by 35
Trojanowski, J. Q., & Lee, V. M.-Y. (2001) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(00)00065-1 · Cited by 32
Dequalinium-induced Protofibril Formation of α-Synuclein
Lee, C., Kim, H. J., Lee, J., Cho, H.-J., Kim, J., Chung, K. C., Jung, S., & Paik, S. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505307200 · Cited by 24
Cited by
The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization
Hamley, I. W. (2012) · Chemical Reviews · doi:10.1021/cr3000994 · Cited by 882
α-Synuclein misfolding and Parkinson's disease
Breydo, L., Wu, J. W., & Uversky, V. N. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.002 · Cited by 657
Biochemistry of Amyloid -Protein and Amyloid Deposits in Alzheimer Disease
Masters, C. L., & Selkoe, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006262 · Cited by 542
Resveratrol: a review of plant sources, synthesis, stability, modification and food application
Tian, B., & Liu, J. (2020) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.10152 · Cited by 497
Small-molecule conversion of toxic oligomers to nontoxic β-sheet–rich amyloid fibrils
Bieschke, J., Herbst, M., Wiglenda, T., Friedrich, R. P., Boeddrich, A., Schiele, F., Kleckers, D., Lopez del Amo, J. M., Grüning, B. A., Wang, Q., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.719 · Cited by 445
Metadata
- Authors
- Ladiwala, A. R. A., Lin, J. C., Bale, S. S., Marcelino-Cruz, A. M., Bhattacharya, M., Dordick, J. S., & Tessier, P. M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2010-07
- Volume
- 285
- Issue
- 31
- Pages
- 24228-24237
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1986267130
- Cited by
- 297
- References
- 97
- FWCI
- 15.60
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.